Dose conversion and titration with a novel, once-daily, OROS osmotic technology, extended-release hydromorphone formulation in the treatment of chronic malignant or nonmalignant pain. - Palangio,M.; Northfelt,DW.; Portenoy,RK. (J Pain Symptom Manage, 2002)